Bernardino A. N.
- Country
- Spain
- Department
- Servicio de Neumologia
Research Overview
- A Randomized, Double‑Blind, Placebo‑Controlled Phase 2/3 Study of Subcutaneous PF‑07275315 in Adults with Moderate‑to‑Severe Chronic Obstructive Pulmonary Disease
- Evaluation of Budesonide, Glycopyrronium Bromide, and Formoterol Fumarate on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease Patients
- Evaluation of Long-Term Safety of Salbutamol Sulfate via MDI with Propellants HFA-152a and HFA-134a in Adults with Asthma
Data & Insights
Has run more than one trial at 103 of 445 partner sites.
Specializations
Respiratory Disease Management
This investigator specializes in advanced therapeutic approaches for chronic respiratory conditions, with particular emphasis on comprehensive treatment strategies for both COPD and asthma.
- COPD Treatment Optimization
- Asthma Management Protocols
- Bronchodilator Therapy
The research focuses on evaluating various therapeutic combinations to enhance respiratory function and patient outcomes.
Innovative Therapeutic Solutions
The investigator explores cutting-edge treatment modalities, including triple therapy approaches and novel inhalation delivery systems for respiratory conditions.
- Advanced Inhaler Technologies
- Combination Therapy Assessment
- Treatment Safety Evaluation
Their work encompasses the evaluation of new propellant technologies and delivery mechanisms in respiratory medicine.
Clinical Outcomes Research
The investigator's work centers on measuring and improving cardiopulmonary outcomes and clinical control in respiratory diseases.
- Exacerbation Prevention
- Disease Stability Assessment
- Long-term Treatment Efficacy
Their research emphasizes the evaluation of therapeutic interventions for high-risk respiratory patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.